Innovative nutraceutical research boosted with gut and gut-brain axis
Make major scientific breakthroughs in your innovative nutraceutical research
Enterosys relies on a highly qualified team and state-of-the-art technical platform to evaluate the efficacy and toxicity of your product candidates in both in vitro and / or in vivo models. We offer efficacy tests that take into account the digestive system and inter-organ communication to develop your nutraceutical leads (ingredients, prebiotics or probiotics). Our holistic approach allow you to develop tomorrow’s preventive medicines.
We accompany you during your innovation process. According to your needs, we design and perform the experimental protocols adapted to the development objectives of your nutraceutical pipeline. To achieve this, we offer a wide range of tests which provide real opportunities for differentiation:
- Screening of potential nutraceutical leads
- Improvement of lead profiling and selection
- Comparison of various compounds in different organs
- Characterization and consolidation of preventive effects
- Characterization and consolidation of mechanisms of action
- Repositioning of your compound
Challenge your ingredients with the expert on the gut and the gut-organ axis!
New legislation, patent expirations and rising healthcare costs are demanding decisive changes in the global nutraceutical industry. You evolve in a very competitive environment, and you need smart solutions?
Enterosys offers rapid and innovative protocols to analyze physiological parameters in real time. Our approaches save time and costs in the development of your nutraceutics to quickly position or reposition your assets and prevent of risk factors. We help researchers to advance the science of precision health.
GUT AND GUT-ORGAN PRECLINICAL STUDIES BOOST THE DEVELOPMENT OF YOUR MOLECULES
ENTEROSYS IS A CRO ROOTED IN THE GUT TO SUPPORT INNOVATIVE NUTRACEUTICAL RESEARCH
Enterosys offers rapid and innovative protocols for the analysis of physiological parameters in real time. Our approaches allow you to save time and costs in the development of your therapeutics to quickly position or reposition your assets. We help researchers to advance science and improve precision health much faster.
Our holistic gut-organ approach demonstrates the beneficial effects of molecules of interest and may also detect potential side effects on other organs very early in the development process. Our cutting-edge expertise allow you to leverage your molecules and to de-risk innovation.
White paper ENTEROSYS
« GUT IS THE LINK »
Our first white paper is now available !
Get inside the head of our co-founder Claude Knauf.
Come discover his background, his key dates, how he got the gut feeling and the link between enteric neurons and glycemic control as well as other health related areas.
OUR KEY SCIENTIFIC FINDINGS ABOUT THE GUT
Enteric neurons for functional applications in health care
In the intestine, gut distension and nutrients are detected by mechanoreceptors and chemoreceptors, respectively. The activation of these receptors sends an afferent nervous message to the hypothalamus in the brain. In turn, the hypothalamus controls the glucose entry in tissues, and thus glycemia.
Enteric neurons and glycemia control
In the intestine, gut distension and nutrients are detected by mechanoreceptors and chemoreceptors, respectively. The activation of these receptors sends an afferent nervous message to the hypothalamus in the brain. In turn, the hypothalamus controls the glucose entry in tissues, and thus glycemia.
The enteric nervous system is our second brain
The enteric nervous system (ENS), referred to as the “second brain,” is an extensive network of different cell types located along the digestive tract.
Do you have a question about the contribution of gut models in your innovative research ?
Our team of experts will be delighted to answer all of your questions. We guide you in the design of an optimized protocol to meet your objectives and add value to your molecules with quick and concrete solutions.